Prevalence of medical adhesive-related skin injury at peripherally inserted central catheter insertion site in oncology patients

Abstract

Introduction:

The aim of our study was to identify the prevalence and risk factors of medical adhesive-related skin injuries (MARSI) at peripherally inserted central catheters (PICC) insertion site in oncology patients.

Methods:

A cross-sectional observational study lasting two weeks was carried out in four inpatient departments. Skin assessment data and photographs of skin were collected during PICC maintenance. Other related information came from medical records. The skin injuries were classified by dermatologists and PICC specialized nurses. MARSI prevalence was calculated and the associated factors were analyzed statistically.

Results:

All 419 patients were included. The prevalence of total MARSI at PICC insertion site was 125, (29.83%), including mechanical skin injury (73, 17.42%), contact dermatitis (CD) (39, 9.31%), moisture-associated skin damage (11, 2.63%), folliculitis (2, 0.48%). Multivariate analysis identified two independent risk factors for MARSI including age ≥50 y (p = 0.031, odds ratio [OR] = 4.521, 95% confidence interval [CI] [1.389, 20.620]) and hematologic malignancies (p = 0.000, OR = 2.514, 95% CI [1.590,3.97]. Oxaliplatin and arsenic trioxide infusion through PICC, history of skin allergies was associated with CD, with p = 0.020, OR = 3.492, 95% CI (1.220, 9.990); p = 0.003, OR = 4.565, 95% CI (1.661,12.547); p = 0.000, OR = 12.333, 95% CI (3.669, 41.454), respectively.

Conclusions:

MARSI at PICC insertion site is a frequent event among oncology patients. Epidemiological data and independent risk factors are presented in our study, which provide a basis for future study in this area.

Keywords

Medical adhesive-related skin injury Oncology Peripherally inserted central catheters Prevalence

Get full access to this article

View all access options for this article.

References

Sharp

Grech

Fielder

Mikocka-Walus

Cummings

Esterman

. The patient experience of a peripherally inserted central catheter (PICC): a qualitative descriptive study. Contemp Nurse. 2014;48(1):26–35.

3M Company. 3M Launches 3M™ Kind Removal Silicone Tape Delivering Securement and Comfort Without Compromise. Available from: http://news.3m.com/press-release/company/3m-launches-3m-kind-removal-silicone-tape-delivering-securement-and-comfort-wi. Accessed August 14, 2017.

McNichol

Lund

Rosen

Gray

. Medical adhesives and patient safety: state of the science: consensus statements for the assessment, prevention, and treatment of adhesive-related skin injuries. Orthop Nurs. 2013;32(5):267–281.

Thayer

. Skin damage associated with intravenous therapy: common problems and strategies for prevention. J Infus Nurs. 2012;35(6):390–401.

Yates

McNichol

Heinecke

Gray

. Embracing the concept, defining the practice, and changing the outcome: setting the standard for medical adhesive-related skin injury interventions in WOC nursing practice. J Wound Ostomy Continence Nurs. 2017;44(1):13–17.

Konya

Sanada

Sugama

et al . Skin injuries caused by medical adhesive tape in older people and associated factors. J Clin Nurs. 2010;19(9-10):1236–1242.

Cutting

. Impact of adhesive surgical tape and wound dressings on the skin, with reference to skin stripping. J Wound Care. 2008;17(4):157–158, 160-162.

Sanusi

. Severe wound traction-blisters after inadequate dressing application following laparoscopic cholecystectomy: case report of a preventable complication. Patient Saf Surg. 2011;5(1):4.

White

Gough

Howie

. Using silicone technology to maintain healthy skin in stoma care. Br J Nurs. 2014;23(22):1188–1193.

10.

Newall

Lewin

Bulsara

Carville

Leslie

Roberts

. The development and testing of a skin tear risk assessment tool. Int Wound J. 2017;14(1):97–103.

11.

Kutzscher

. Management of irritant contact dermatitis and peripherally inserted central catheters. Clin J Oncol Nurs. 2012;16(2):E48–E55.

12.

Hitchcock

Savine

. Medical adhesive-related skin injury: VADS and dressings. Br J Nurs. 2015;24(Suppl 14):S13.

13.

Willemsen

van Valburg

Dirven-Meijer

Oranje

van der Wouden

Moed

. Determining the severity of atopic dermatitis in children presenting in general practice: an easy and fast method. Dermatol Res Pract. 2009;2009:357046.

14.

Edsberg

Black

Goldberg

McNichol

Moore

Sieggreen

. Revised National Pressure Ulcer Advisory Panel Pressure Injury Staging System: Revised Pressure Injury Staging System. J Wound Ostomy Continence Nurs. 2016;43(6):585–597.

15.

Farris

Petty

Hamilton

Walters

Flynn

. Medical Adhesive-Related Skin Injury Prevalence Among Adult Acute Care Patients: A Single-Center Observational Study. J Wound Ostomy Continence Nurs. 2015;42(6):589–598.

16.

Pedrolo

Danski

Vayego

. Chlorhexidine and gauze and tape dressings for central venous catheters: a randomized clinical trial. Rev Lat Am Enfermagem. 2014;22(5):764–771.

17.

Noonan

Quigley

Curley

. Skin integrity in hospitalized infants and children: a prevalence survey. J Pediatr Nurs. 2006;21(6):445–453.

18.

Ter

Yavuz

Aydoğdu

Kaya Biçer

. The effect of 2 adhesive products on skin integrity used for fixation of hip and knee surgical dressings: a randomized controlled trial. J Wound Ostomy Continence Nurs. 2015;42(2):145–150.

19.

Rietschel

. Clues to an accurate diagnosis of contact dermatitis. Dermatol Ther. 2004;17(3):224–230.

20.

Timsit

Schwebel

Bouadma

et al ; Dressing Study Group. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA. 2009;301(12):1231–1241.

21.

Litton

. Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. J Antimicrob Chemother. 2006;58(2):281–287.

22.

Campbell

Coyer

Osborne

. The skin safety model: reconceptualizing skin vulnerability in older patients. J Nurs Scholarsh. 2016;48(1):14–22.

23.

Wall

Divito

Talbot

. Chlorhexidine gluconate-impregnated central-line dressings and necrosis in complicated skin disorder patients. J Crit Care. 2014;29(6):1130. e1–1130.e4.

24.

Zhai

Meier-Davis

Cayme

Shudo

Maibach

. Irritant contact dermatitis: effect of age. Cutan Ocul Toxicol. 2012;31(2):138–143.

25.

Waring

Bielfeldt

Mätzold

Wilhelm

. A new methodology for evaluating the damage to the skin barrier caused by repeated application and removal of adhesive dressings. Skin Res Technol. 2013;19(1):e366–e374.

26.

Stephen-Haynes

. Skin integrity and silicone: Appeel no-sting medical adhesive remover. Br J Nurs. 2008;17(12):792–795.

27.

Fore

. A review of skin and the effects of aging on skin structure and function. Ostomy Wound Manage. 2006;52(9):24–35, quiz 36–37.

28.

Morano

Latagliata

Girmenia

et al . Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC). Support Care Cancer. 2015;23(11):3289–3295.

29.

Dararattanaroj

Pootongkam

Rojanawatsirivej

Liwsrisakun

Wongpiyabovorn

. Patterns and risk factors of causative contact allergens in Thai adult patients with contact dermatitis at King Chulalongkorn Memorial Hospital. Asian Pac J Allergy Immunol. 2017;35(1):27–32.

30.

Kasemsarn

Iamphonrat

Boonchai

. Risk factors and common contact allergens in facial allergic contact dermatitis patients. Int J Dermatol. 2016;55(4):417–424.

31.

Chen

. A meta-analysis of arsenic trioxide combined with transcatheter arterial chemoembolization for treatment of primary hepatic carcinoma. Evid Based Complement Alternat Med. 2016;2016:3428370.

32.

Breccia

Lo-Coco

. Arsenic trioxide for management of acute promyelocytic leukemia: current evidence on its role in front-line therapy and recurrent disease. Expert Opin Pharmacother. 2012;13(7):1031–1043.

33.

Maindrault-Goebel

André

Tournigand

et al . Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients. Eur J Cancer. 2005;41(15):2262–2267.

34.

Mehmood

. Review of cisplatin and oxaliplatin in current immunogenic and monoclonal antibody treatments. Oncol Rev. 2014;8(2):256.